UL To Expand Services at New Mounds View, Minnesota, Location
08/07/2013
UL said it is relocating from its current location southeast of Mounds View, in Vadnais Heights, to expand on its existing high-tech and medical safety engineering and testing services to now offer local Human Factors Engineering services, Home Healthcare as well as access to comprehensive services to support medical and IVD manufacturers with regulatory submissions in global markets.
"Minnesota has one of the most active and innovative medical device clusters in the nation and we are pleased to be able to place some of our top talent to support this area locally," said Joe Madden, Global Sales Director for UL's Health Sciences Division. "Now manufacturers have local access to the full product lifecycle services UL provides to support challenges that manufacturers face when trying to get their approvals."
In 2012, UL acquired Wiklund R&D located in Concord, MA, bringing years of knowledge in Human Factors Engineering for medical and other devices. The new office in Mounds View Minnesota will be the first major expansion of that service within North America.
Project Announcements
EPC-Columbia Plans Fremont, Ohio, Manufacturing Operations
11/05/2025
Aclara Resources Plans Calcasieu Parish, Louisiana, Heavy Rare Earth Separation Operations
11/04/2025
KCG Engineering Group Plans Chesapeake, Virginia, Operations
11/04/2025
Morin Establishes Little Rock, Arkansas, Operations
11/03/2025
Provalus Plans West Plains, Missouri, Operations
11/01/2025
Eos Energy Enterprises Expands Allegheny County, Pennsylvania, Operations
11/01/2025
Most Read
-
2025’s Top States for Business: How the Winners Are Outpacing the Rest
Q3 2025
-
The Compliance Reckoning Is Here
Q3 2025
-
Around the Horn: Data Center Supply Chains — What's Next?
Q3 2025
-
How Consumer Trends Are Reshaping Food Facilities
Q3 2025
-
First Person: Filter King’s Expansion Playbook
Q3 2025
-
Rethinking Auto Site Strategy in the Age of Tariffs and Powertrain Shifts
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025